DV
Dividend Vision

AMPH — Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc. (AMPH)

Total return is 139.0% over the past 12.1 years, 246.5 points behind SPY at 385.5%. Its deepest 1-year drawdown was 45.2%.

Amphastar Pharmaceuticals Inc. is a single-stock equity holding that represents ownership in a pharmaceutical company focused on generic and specialty injectable drugs. The holding does not currently maintain a regular dividend distribution, making it unsuitable for income-focused investors seeking yield. This equity position appeals primarily to growth-oriented investors interested in pharmaceutical sector exposure rather than dividend income strategies.

AMPH key facts

Asset type
Stock
Asset class
Equity
Inception date
06/25/2014
Distribution frequency
None
Last close
$20.91
Market cap
$889,468,416
Average volume
305681.0
Beta
0.901
Payout ratio
0.0
P/E ratio
11.9486
Forward P/E
0.0
EPS
$1.75